Filing Flows › Bio-Rad Laboratories (BIO) › Capital expenditures
Bio-Rad Laboratories (BIO) capital expenditures by quarter
Bio-Rad Laboratories' capital expenditures were $31.2M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $30.0M (Q1 2026) to $45.8M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $31.2M | -3% | -2% |
| Q2 2026 | $32.0M | +7% | -30% |
| Q1 2026 | $30.0M | -34% | -13% |
| Q4 2025 | $45.8M | +44% | — |
| Q3 2025 | $31.7M | -31% | — |
| Q2 2025 | $45.7M | +33% | — |
| Q1 2025 | $34.4M | — | — |
Q3 2026 at a glance
Bio-Rad Laboratories, Q3 2026: revenue $656M (+0.5% year over year), operating margin -7.6%, net earnings $459M, operating cash flow $96.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio-Rad Laboratories' capital expenditures?
Bio-Rad Laboratories' capital expenditures were $31.2M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Bio-Rad Laboratories' capital expenditures changed?
Over the last 7 quarters it ranged from $30.0M (Q1 2026) to $45.8M (Q4 2025).